Frontlight ResearchEarly access
Myelodysplastic syndromes trials in United States
224 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peoplePhase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
- Where
- Philadelphia
- Age
- 1 month to 25 years
- People
- 100
- Run by
- Children's Hospital of Philadelphia
See details and how to joinNCT06839456 - No phaseTaking peopleThe Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
- Where
- Winston-Salem
- Age
- 18 years to 120 years
- People
- 2,000
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT01890486 - Phase 1/2Taking peopleA Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
- Where
- Charlottesville, Chicago, Houston, Jacksonville, Phoenix, Rochester, Seattle
- Age
- 18 years and over
- People
- 225
- Run by
- Chordia Therapeutics, Inc.
See details and how to joinNCT05732103 - Phase 1Taking peopleUAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy
- Where
- Birmingham
- Age
- 4 weeks to 75 years
- People
- 50
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT06047886 - Phase 1Taking peopleA Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
- Where
- Buffalo, Duarte, Houston, Irvine, Kansas City, Merriam, New York
- Age
- 18 years and over
- People
- 48
- Run by
- GluBio Therapeutics Inc.
See details and how to joinNCT06146257 - Phase 2Taking peopleBMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)
- Where
- Chicago
- Age
- 18 years to 75 years
- People
- 27
- Run by
- University of Illinois Chicago
See details and how to joinNCT04187105 - Phase 2Taking peopleMT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
- Where
- Minneapolis
- Age
- Up to 60 years
- People
- 70
- Run by
- Masonic Cancer Center, University of Minnesota
See details and how to joinNCT05735717 - Phase 1Taking peopleIadademstat With Hypomethylating Agent in Patients With Myelodysplastic Syndrome
- Where
- Milwaukee
- Age
- 18 years and over
- People
- 12
- Run by
- Medical College of Wisconsin
See details and how to joinNCT06502145 - Phase 2Taking peopleCurcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 30
- Run by
- University of Southern California
See details and how to joinNCT06063486 - Early phase 1Taking peopleMomelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia
- Where
- Baltimore
- Age
- 18 years to 100 years
- People
- 18
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT07071155 - Phase 1Taking peopleExpanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
- Where
- Columbus, Westwood
- Age
- 18 years to 65 years
- People
- 38
- Run by
- University of Kansas Medical Center
See details and how to joinNCT03533816 - Phase 1Taking peopleSafety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes
- Where
- Houston, New York
- Age
- 18 years and over
- People
- 24
- Run by
- Remedy Plan, Inc.
See details and how to joinNCT07107126 - Phase 1/2Taking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Baltimore, Boston, Buffalo, Chapel Hill, Charleston, Charlottesville, Chicago, Columbus, Denver, Durham, Eugene, Fairfax, Houston, Miami, Morristown, Nashville, New Brunswick, Newport Beach, New York, Norfolk, Palo Alto, Philadelphia, Pittsburgh, Salt Lake City, Tampa, Washington D.C., Winston-Salem
- Age
- 12 years and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555 - Phase 1/2Taking peoplePre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant
- Where
- St Louis
- Age
- 18 years to 75 years
- People
- 209
- Run by
- Washington University School of Medicine
See details and how to joinNCT04742634 - Phase 2Taking peopleA Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- Where
- Birmingham, Boston, Chapel Hill, Charlottesville, Detroit, Duarte, Houston, Miami, New York, Palo Alto, Portland, Seattle, Westwood
- Age
- 18 years to 66 years
- People
- 358
- Run by
- Center for International Blood and Marrow Transplant Research
See details and how to joinNCT06859424 - Phase 1Taking peopleA Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
- Where
- Boston, Chicago, Duarte, Houston, Nashville, New York, Palo Alto, Philadelphia, St Louis, Tampa
- Age
- 12 years and over
- People
- 72
- Run by
- Crossbow Therapeutics, Inc.
See details and how to joinNCT06994676 - Phase 2Taking peopleCord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
- Where
- New York
- Age
- Up to 21 years
- People
- 31
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT04644016 - Phase 1Taking peopleVenetoclax Basket Trial for High Risk Hematologic Malignancies
- Where
- Atlanta, Aurora, Boston, Chicago, San Francisco
- Age
- 1 year to 40 years
- People
- 30
- Run by
- Andrew E. Place, MD
See details and how to joinNCT05292664 - Phase 1Taking peopleTrial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies
- Where
- Birmingham
- Age
- 18 years to 75 years
- People
- 20
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT07044544 - Phase 1Taking peopleFHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia
- Where
- The Bronx
- Age
- 18 years and over
- People
- 33
- Run by
- Montefiore Medical Center
See details and how to joinNCT07283094 - No phaseTaking peoplePre-myeloid Cancer and Bone Marrow Failure Clinic Study
- Where
- Jacksonville, Rochester, Scottsdale
- Age
- 18 years and over
- People
- 2,000
- Run by
- Mayo Clinic
See details and how to joinNCT02958462 - No phaseTaking peopleDefining Inflammatory Markers of Cardiovascular Disease in Patients With Myelodysplastic Syndromes
- Where
- Burlington
- Age
- 18 years and over
- People
- 30
- Run by
- University of Vermont
See details and how to joinNCT06692894 - Phase 2Taking peopleAlpha/Beta TCD HCT in Patients With Inherited BMF Disorders
- Where
- Minneapolis
- Age
- Up to 65 years
- People
- 48
- Run by
- Masonic Cancer Center, University of Minnesota
See details and how to joinNCT03579875 - Phase 1Taking peopleA Study of Oral Tetrahydrouridine-Decitabine in Relapsed or Refractory Myelodysplastic Syndromes (MDS)
- Where
- The Bronx
- Age
- 18 years and over
- People
- 20
- Run by
- Treebough Therapies
See details and how to joinNCT07006025 - Phase 1Taking peopleVenetoclax Plus Intensive Chemotherapy in AML and Advanced MDS
- Where
- The Bronx
- Age
- 18 years to 75 years
- People
- 99
- Run by
- Montefiore Medical Center
See details and how to joinNCT05342584